Univ. Pompeu Fabra; Hospital del Mar Medical Research Institute (IMIM)
Email verificata su upf.edu
Citata da
Citata da
A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells
M Colonna, F Navarro, T Bellón, M Llano, P García, J Samaridis, ...
The Journal of experimental medicine 186 (11), 1809-1818, 1997
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
N Lee, M Llano, M Carretero, A Ishitani, F Navarro, M López-Botet, ...
Proceedings of the National Academy of Sciences 95 (9), 5199-5204, 1998
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
F Garrido, F Ruiz-Cabello, T Cabrera, JJ Perez-Villar, M López-Botet, ...
Immunology today 18 (2), 89-95, 1997
Guidelines for the use of flow cytometry and cell sorting in immunological studies
A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ...
European journal of immunology 49 (10), 1457-1973, 2019
Imprint of human cytomegalovirus infection on the NK cell receptor repertoire
M Gumá, A Angulo, C Vilches, N Gómez-Lozano, N Malats, ...
Blood 104 (12), 3664-3671, 2004
Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts
M Gumá, M Budt, A Sáez, T Brckalo, H Hengel, A Angulo, M López-Botet
Blood 107 (9), 3624-3631, 2006
The ILT2 (LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA‐G1 and HLA‐E molecules co‐expressed on target cells
F Navarro, M Llano, T Bellón, M Colonna, DE Geraghty, M López‐Botet
European journal of immunology 29 (1), 277-283, 1999
Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2‐A and the activating receptor CD94/NKG2‐C to HLA‐E
M Valés‐Gómez, HT Reyburn, RA Erskine, M López‐Botet, JL Strominger
The EMBO journal 18 (15), 4250-4260, 1999
HLA‐E‐bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA‐G‐derived nonamer
M Llano, N Lee, F Navarro, P García, JP Albar, DE Geraghty, ...
European journal of immunology 28 (9), 2854-2863, 1998
Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes.
M Cebrián, E Yagüe, M Rincon, M López-Botet, MO De Landazuri, ...
The Journal of experimental medicine 168 (5), 1621-1637, 1988
The CD94 and NKG2‐AC‐type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules
M Carretero, C Cantoni, T Bellón, C Bottino, R Biassoni, A Rodríguez, ...
European journal of immunology 27 (2), 563-567, 1997
Selective expansion of intraepithelial lymphocytes expressing the HLA-E–specific natural killer receptor CD94 in celiac disease
B Jabri, NPM De Serre, C Cellier, K Evans, C Gache, C Carvalho, ...
Gastroenterology 118 (5), 867-879, 2000
Molecular characterization of human CD94: a type II membrane glycoprotein related to the C‐type lectin superfamily
C Chang, A Rodríguez, M Carretero, M López‐Botet, JH Phillips, ...
European journal of immunology 25 (9), 2433-2437, 1995
Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1–positive patients
M Gumá, C Cabrera, I Erkizia, M Bofill, B Clotet, L Ruiz, M López-Botet
The Journal of infectious diseases 194 (1), 38-41, 2006
Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C.
KS Campbell, M Dessing, M Lopez-Botet, M Cella, M Colonna
The Journal of experimental medicine 184 (1), 93-100, 1996
Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles.
A Moretta, M Vitale, S Sivori, C Bottino, L Morelli, R Augugliaro, ...
The Journal of experimental medicine 180 (2), 545-555, 1994
A novel family of Ig‐like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells
M Colonna, H Nakajima, F Navarro, M López‐Botet
Journal of leukocyte biology 66 (3), 375-381, 1999
2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin activation of the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator pathway causes developmental toxicity through …
SA Carney, RE Peterson, W Heideman
Molecular pharmacology 66 (3), 512-521, 2004
MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine
J Bousquet, J Anto, C Auffray, M Akdis, A Cambon‐Thomsen, T Keil, ...
Allergy 66 (5), 596-604, 2011
NK cell recognition of non-classical HLA class I molecules
M Lopez-Botet, M Llano, F Navarro, T Bellon
Seminars in immunology 12 (2), 109-119, 2000
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20